AstraZeneca Pharma India Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Profit before tax

134.10

83.04

127.09

113.97

72.67

Net cashflow-operating activity

58.29

100.80

104.78

87.42

54.98

Net cash used in investing activity

18.11

4.74

173.03

-170.80

4.28

Netcash used in fin. activity

-24.48

-9.46

-8.97

-6.36

-

Net inc/dec in cash and equivlnt

51.92

96.08

268.84

-89.74

59.26

Cash and equivalnt begin of year

448.42

352.34

83.50

173.24

113.98

Cash and equivalnt end of year

500.34

448.42

352.34

83.50

173.24